drugset / Trial / NCT01069822
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
Non-randomizedSingle-groupOpen-label
Summary
The main purpose of this study is to evaluate the effect repeated doses of AZD6765 (a drug being developed for the treatment of patients with severe major depressive disorder) has on the PK (pharmacokinetic) profile of Midazolam. (The PK profile is how the drug leaves your body and acts in the body.)
Timeline
- Start
- 2010-02
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | lanicemine | Small molecule | — | Intravenous |
Indications
No indication recorded.